These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11166879)

  • 1. Vaccines for the developing world: current status and future directions.
    Wenger J
    Vaccine; 2001 Feb; 19(13-14):1588-91. PubMed ID: 11166879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines for children in rich and poor countries.
    Shann F; Steinhoff MC
    Lancet; 1999 Sep; 354 Suppl 2():SII7-11. PubMed ID: 10507252
    [No Abstract]   [Full Text] [Related]  

  • 3. Availability of quality vaccines: policies of a non-government organization.
    Poore P
    Vaccine; 1992; 10(13):958-60. PubMed ID: 1471421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunization in developing countries: practical and theoretical problems and prospects.
    Arya SC
    Vaccine; 1994 Nov; 12(15):1423-35. PubMed ID: 7887021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines and future global health needs.
    Nossal GJ
    Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2833-40. PubMed ID: 21893548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstacles to developing vaccines for the Third World.
    Robbins A; Freeman P
    Sci Am; 1988 Nov; 259(5):126-33. PubMed ID: 3212439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for the use of new vaccines in developing countries: cost is not the only impediment.
    Hausdorff WP
    Vaccine; 1996 Sep; 14(13):1179-86. PubMed ID: 8961503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Children's Vaccine Initiative and vaccine supply: the role of the public sector.
    van Noort RB
    Vaccine; 1992; 10(13):909-10. PubMed ID: 1471410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines, global health and social equity.
    Levine MM; Robins-Browne R
    Immunol Cell Biol; 2009; 87(4):274-8. PubMed ID: 19308074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluations of hepatitis B vaccination for developing countries.
    Tu HA; Woerdenbag HJ; Kane S; Riewpaiboon A; van Hulst M; Postma MJ
    Expert Rev Vaccines; 2009 Jul; 8(7):907-20. PubMed ID: 19538116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine stability in the context of vaccine delivery in a developing country: India.
    John TJ
    Dev Biol Stand; 1996; 87():19-25. PubMed ID: 8853998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Why are boosters no longer necessary for protection against hepatitis B?].
    Siegrist CA
    Rev Prat; 2004 Mar; 54(5):509-11. PubMed ID: 15176509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines--endangered species?
    Nat Immunol; 2002 Aug; 3(8):695. PubMed ID: 12145649
    [No Abstract]   [Full Text] [Related]  

  • 14. DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.
    Michel ML; Loirat D
    Intervirology; 2001; 44(2-3):78-87. PubMed ID: 11509869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Licensing IP to ensure accessibility to vaccines and other immunisation-related products.
    Mehta JM
    Vaccine; 2001 Feb; 19(13-14):1581-7; discussion 1592-3. PubMed ID: 11166878
    [No Abstract]   [Full Text] [Related]  

  • 16. The introduction of new vaccines into developing countries II. Vaccine financing.
    Mahoney RT; Ramachandran S; Xu Z
    Vaccine; 2000 Jun; 18(24):2625-35. PubMed ID: 10781848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B vaccines: WHO position paper – July 2017.
    Wkly Epidemiol Rec; 2017 Jul; 92(27):369-92. PubMed ID: 28685564
    [No Abstract]   [Full Text] [Related]  

  • 18. Foreword. Hepatitis B and the impact of immunization in China and the WHO Western Pacific Region.
    Yu W
    Vaccine; 2013 Dec; 31 Suppl 9():J2. PubMed ID: 24331016
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B?
    Gehring S; Pietrzak-Nguyen A; Fichter M; Landfester K
    Nanomedicine (Lond); 2017 Jun; 12(11):1205-1207. PubMed ID: 28517963
    [No Abstract]   [Full Text] [Related]  

  • 20. A framework for the evaluation of vaccines for use in the expanded programme on immunization.
    Aylward B; Kane M; Batson A; Scott RM
    Vaccine; 1994 Oct; 12(13):1155-9. PubMed ID: 7839719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.